PLK1 and lung adenocarcinoma: demonstrated a decrease in the expression of KPNB1, a cell survival‐promoting protein, as one of the first steps during the induction of apoptosis after Plk1 inhibition in lung adenocarcinoma (Sekimoto et al., 2017).